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A role for the tyrosine kinase ACK1 in neurotrophin
signaling and neuronal extension and branching
A La Torre1,2,6,7, M del Mar Masdeu1,2,3,7, T Cotrufo1,2,3, RS Moubarak3,4, JA del Rı´o2,3,5, JX Comella3,4, E Soriano1,2,3
and JM Uren˜a*,1,2,3
Neurotrophins are involved in many crucial cellular functions, including neurite outgrowth, synapse formation, and plasticity.
Although these events have long been known, the molecular determinants underlying neuritogenesis have not been fully
characterized. Ack1 (activated Cdc42-associated tyrosine kinase) is a non-receptor tyrosine kinase that is highly expressed in
the brain. Here, we demonstrate that Ack1 is a molecular constituent of neurotrophin signaling cascades in neurons and PC12
cells. We report that Ack1 interacts with Trk receptors and becomes tyrosine phosphorylated and its kinase activity is increased
in response to neurotrophins. Moreover, our data indicate that Ack1 acts upstream of the Akt and MAPK pathways. We show that
Ack1 overexpression induces neuritic outgrowth and promotes branching in neurotrophin-treated neuronal cells, whereas the
expression of Ack1 dominant negatives or short-hairpin RNAs counteract neurotrophin-stimulated differentiation. Our results
identify Ack1 as a novel regulator of neurotrophin-mediated events in primary neurons and in PC12 cells.
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Nervous system functions require exquisitely precise neuronal
circuits. The patterning and specificity of these connections
are dependent on specific signals, including guidance cues
and growth factors. Overall, neurons exhibit type-specific
patterns of neuritic arbors that define the physiological
properties of each neuronal population. Moreover, these
dendritic and axonal trees are sculpted and refined by
environmental signals.1–5 Neurotrophins have critical roles in
neuronal differentiation.6–8 They comprise a family of structu-
rally and functionally related proteins: nerve growth factor
(NGF), brain-derived neurotrophic factor (BDNF), neurotro-
phin-3 (NT-3), and neurotrophin-4/5 (NT-4/5). Neurotrophin
signals are transduced through Trk receptor tyrosine
kinases and p75 receptor (p75NTR).9–11 The activation of
Trk receptors triggers the dimerization, kinase activation, and
autophosphorylation of the receptors, followed by the activa-
tion of several signaling pathways, including Ras/MAPK and
PI3K/Akt.
The Activated Cdc42-associated tyrosine kinase (Ack1) is a
non-receptor tyrosine kinase that was originally characterized
as a target of the Rho protein Cdc42.12 The domain structure
of Ack1 is unique among cytosolic kinases and contains an SH3
domain C-terminal to the kinase domain, a Cdc42/Rac inter-
active binding (CRIB) module, and a huge polyproline region.
In addition, Ack1 also interacts with the molecular adaptor
Grb2,13 as well as with the kinases Src, Fyn, and Hck,14–16 the
Ras-exchange factor Ras-GRF1,17 Dbl,18 and the Wiskott-
Aldrich Syndrome Protein (WASP),19 among others.
There is evidence that Ack1 is activated by a variety of
extracellular cues, including growth factors, M3 muscarinic
receptors, and chondroitin sulfate proteoglycans.13,14,20
Furthermore, Ack1 is recruited to activated RTK, such as
EGFR and PDGFR.21,22 Several studies have demonstrated
that Ack2 (an isoform of Ack isolated from bovine brain)
coordinates changes in cell morphology required for differ-
entiation, including the re-organization of the actin cyto-
skeleton.15,23 In previous studies, we showed that Ack1 is
highly expressed in the central nervous system (CNS) during
adulthood and in developing neurons.24,25 In neuronal
cultures and in vivo, Ack1 is localized in developing dendrites
and axons, including growth cones, presynaptic terminals,
and dendritic spines. Here, we demonstrate that this kinase is
activated by Trk signaling in neurons. To further address the
cellular functions of Ack1 in response to neurotrophins, we
studied the effects of Ack1 overexpression and downregula-
tion in several neuronal models. Ack1 stimulated neuronal
arborization and this effect was enhanced by neurotrophins.
These findings provide evidence of the involvement of Ack1 in
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neurotrophin signaling pathways and indicate a novel role for
this tyrosine kinase in neuronal differentiation.
Results
Monoclonal antibody preparation. Monoclonal antibodies
were generated against a GST-Ack1 fusion protein. To
characterize the immunological properties of the anti-
bodies, we analyzed the detection of Ack1 by western blot
in human embryonic kidney 293T (HEK 293T) cells
transfected with Ack1 (Figure 1a) and in brain lysates
immunoprecipitated with the same monoclonal antibodies
(Figure 1b). Negative controls showed no band in brain
lysates (Figure 1b) or in transfected HEK 293T cells
(Figure 1a). Immunofluorescence of Ack1-transfected
HEK 293T cells showed intracellular labeling (Figure 1c)
equivalent to previously described antibodies.24,25 Two
monoclonal antibodies, 23 and 25, were found to give
strong signals in western blots, immunolocalization and
immunoprecipitation assays (Figures 1a–c).
Ack1 is tyrosine phosphorylated upon stimulation by
neurotrophins. Serum-starved PC12 cells were treated for
5–60min with NGF (50 ng/ml). Subsequently, lysates were
immunoprecipitated with an anti-Ack1 antibody and analyzed
by western blotting with an anti-phosphotyrosine antibody.
We detected a clear increase in endogenous Ack1 phos-
phorylation levels upon NGF stimulation (Figure 1d) that
reached maximum levels between 5 and 15min post
treatment (Figures 1d and e). We also observed concomitant
tyrosine phosphorylation of Trk receptors immunoprecipi-
tated using a pan-Trk antibody (Figure 1d). To establish
whether other neurotrophins also stimulate neuronal Ack1,
forebrain primary cultures were grown for 7 days and were
then stimulated with either BDNF or NT-3. Ack1 phosphor-
ylation levels were significantly increased after a 5-min
stimulation with BDNF or NT-3 (Figures 1f–i). Again,
neurotrophin treatments resulted in tyrosine phosphorylation
of Trk receptors (Figures 1f and h).
In addition, tyrosine phosphorylation was also observed
when neurons were pre-treated with Src inhibitor PP2
(Supplementary Figure 1).Under these conditions, a
modest increase in Ack1 phosphorylation was detected,
whereas phospho-Akt was dramatically inhibited due to
Src inhibition, thus indicating that Ack1 activation after
neurotrophin stimuli is not dependent on Src activity
(Supplementary Figure 1).
To ascertain whether neurotrophins regulate Ack1 kinase
activity, PC12 cells and cortical neurons were treated with
neurotrophins (NGF, BDNF, NT-3). This treatment produced
a modest but significant increase in Ack1 kinase activity
(Figure 1j), consistent with the increase in phosphorylation
levels previously detected. In addition, transfected HEK 293T
cells showed a high increase in the kinase activity of Ack1 as a
result of its overexpression. Such an increase was not
observed in constructs lacking kinase domain or with a
mutation in the active site (Figure 1k) with similar levels
(Supplementary Figure 2). We thus concluded that members
of the neurotrophin family lead to Ack1 tyrosine phosphoryla-
tion and kinase activation.
Ack1 interacts with Trk receptors but not with p75NTR.
To address the role of Ack1 in neurotrophic receptor
signaling pathways, we studied the interaction between
Ack1 and Trk receptors, and Ack1 and p75NTR. For this
purpose, HEK 293T cells were co-transfected with hemag-
glutinin (HA)-tagged Ack1,25 and one of the following cDNAs:
TrkA, GFP-tagged TrkB,26 Myc-tagged TrkC27 or p75NTR
constructs28 (Figure 2).
Lysates from HEK 293T cells transfected either with an
empty vector as a control or with Ack1, TrkA or with both
constructs simultaneously (Figure 2a), and immunoprecipi-
tated with anti-HA or with anti-TrkA antibody revealed TrkA
after immunoprecipitation with anti-HA (upper panel, fourth
lane) as well as Ack1 after Trk immunoprecipitation (third
panel, fourth lane). When cells co-transfected with plasmids
coding for Ack1-HA and GFP-TrkB were immunoprecipitated
with either anti-HA or anti-GFP antibodies, the corresponding
partner was detected by western blot (Figure 2b). Similar
results were obtainedwhenwe co-transfected HEK 293T cells
with TrkC-Myc and Ack1-HA (Figure 2c). Cell lysates were
immunoprecipitated either with anti-Myc or with anti-HA
antibodies and the reciprocal interacting protein in the
resulting immunoprecipitates was detected by western blot
(Figure 2c). However, when the same experiments were
performed with plasmids corresponding to p75NTR and Ack1-
HA, the complementary protein was not detected (Figure 2d).
These results indicate that Ack1 co-immunoprecipitates with
Trk receptors but not with the p75NTR receptor.
We performed Ack1/TrkB immunoprecipitations in brain
lysates from embryonic E16 brains. Here, we observed
co-immunoprecipitation between the two proteins when we
immunoprecipitated Ack1 (Figure 2e) and TrkB (Figure 2f).
NGF leads to a subcellular redistribution of Ack1 in
PC12 cells. In developing and adult neurons, Ack1 shows a
cytoplasmic distribution,24,25 while in some cell lines it shows
a punctuate pattern in the cell cytoplasm and perinuclear
regions.21 Given the observation of the interaction between
neurotrophin receptors and Ack1, we applied immunolabel-
ing to analyze whether neurotrophin treatments cause a
redistribution of Ack1 expression in PC12 cells. While
starved cells showed the expected punctuated expression
pattern (Figure 3a), short stimulations with 50 ng/ml of NGF
(5min) induced a clear re-arrangement of Ack1 protein
distribution, which was reflected by the presence of Ack1
aggregates in the outer edges of the cells in 460% of the
analyzed cells (Figures 3b and c). In these conditions, Ack1
immunostaining greatly co-localized with NGF (Figures 3d–i).
Furthermore, stimulation of PC12 cells with NGF led to
strong co-localization of Ack1 and TrkA, which formed
clusters located near the cell surface (Figures 3j–l).
In addition, we performed co-localization experiments with
filamental actin (F-actin). In control PC12 cells, a significant
part of the Ack1 protein showed partial co-localization with
F-actin, which was present mainly in perinuclear areas
(Figures 3m–o). Interestingly, when PC12 cells were incu-
bated with NGF, co-localization of Ack1 and F-actin was also
detected in protruding tips at the cell surface, as demonstrated
by Phalloidin-FITC co-staining with anti-Ack1 antibody
(Figures 3p–u). The re-arrangement of Ack1 protein
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distribution after stimulation with NGF suggests that part of
the activated pool of Ack1 is detected close to NGF-activated
regions, which might result in protruding edges.
PC12 cells overexpressing Ack1 show increased
neuritic outgrowth. To elucidate whether Ack1 affects
neuronal differentiation, we established PC12 cell lines
Figure 1 Neurotrophin-dependent phosphorylation of Ack1 protein. Monoclonal antibodies against Ack1 show detection by western blot in HEK 293T cells overexpressing
Ack1 (a), and by co-immunoprecipitation and western blot in brain lysates (b). In addition, immunofluorescence with the antibodies in Ack1-transfected HEK 293 cells shows
differential labeling in the transfected cells compared with non-transfected ones (c) using antibody 25. For immunoprecipitation experiments, 20% of the input was loaded into
the gel. PC12 (d and e) and neuronal cultures (f–i) were treated for 5, 15, 30, and 60 min with 50 ng/ml of NGF (d and e), BDNF (f and g), or NT-3 (h and i). (d, f, and h)
Western blot analyses of phospho-Ack1 (upper panels) and phospho-Trk (third panels) and their loading controls are shown. Neurotrophin treatments induced tyrosine
phosphorylation of Ack1 and Trk receptors. Ack1 activation was observed from 5 to 15 min. (e, g, and i) Densitometric analyses of 5–7 independent experiments normalized to
untreated samples (t¼ 0) showing neurotrophin-dependent Ack1 phosphorylation are represented. Each point is represented as mean±S.E.M. (**Po0.05; ***Po0.001).
Each group was compared with their corresponding control at t¼ 0 by T-test. (j) In vitro kinase assay shows activation of Ack1 by neurotrophin treatment in PC12 cells (NGF
dependent), and primary hippocampal neurons (BDNF and NT-3 responsive). (j) Groups were compared with their corresponding control at time 00. (k) In transfected HEK
293T cells, we detected clear activation in Ack1-overexpressing cells and basal levels of activation in Ack1-KD- or Ack1-PR-overexpressing cells. Each group was compared
with control cells using T-test (**Po0.05; ***Po0.001)
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stably overexpressing the wild-type Ack1 cDNA. PC12 cells
have been extensively used as a model of differentiation.29,30
Two clones (named as PC12-Ack#1 and Ack#2) were
obtained and presented increased intracellular levels of
Ack1 protein (about 3–5 times), in comparison with control
cells by western blot assays (Figures 4b and c). Interestingly,
a considerable proportion of Ack1-overexpressing PC12 cells
displayed a flattened phenotype and extended neurites even
in NGF-free medium (Figure 4a), and the percentage of
differentiated cells increased with time (Figure 4d).
To study whether Ack1 influenced NGF-dependent neurite
growth, time-course experiments were performed. Ack1-
overexpressing cells responded to NGF, and the fraction of
cells with neurites was significantly higher at all time points
compared with control cells (PC12 or PC12-pRK5, Figures 4e
and f), as was the total neuritic arbor length (Figure 4g).
Interestingly, we also observed an increased number of
branching points in PC12-Ack1 cells, which was especially
evident at 10 DIV (Figures 4e and h). These data indicate that
Ack1 overexpression increases neuronal differentiation and
neurite complexity in NGF-stimulated and unstimulated PC12
cells.
Endogenous Ack1 protein influences NGF-induced
neuritic outgrowth in PC12 cells. Ack1 overexpression
led to the appearance of numerous neurites, and NGF
enhanced this effect. We hypothesized that Ack1 is involved
in neurotrophin-mediated differentiation in PC12 cells. To
evaluate the role of endogenous Ack1 in neurite-outgrowth
events, we used several RNAi constructs that target distinct
sites of the Ack1 sequence (Sigma’s Mission TRC shRNA
lentiviral-based constructs, Sigma). We generated stably
transfected PC12 cell lines with short-hairpin RNA (shRNA)-
expressing vectors and analyzed the capacity of each RNAi
to knock down endogenous Ack1 expression in PC12 cells.
Two of these cell lines showed a dramatic decrease in Ack1
protein expression (Figures 4j and k) compared with wild-
type PC12 cells or with control RNAi (scrambled-shRNA), as
demonstrated by western blot analysis. To study the effect of
Ack1 silencing on NGF-induced differentiation, PC12 cell
lines were treated with 50 ng/ml of NGF for several days,
and the neuritic processes were monitored. RNAi-mediated
knock-down of Ack1 partially counteracted NGF-induced
outgrowth after 5–10 days of treatment (Figures 4i, l, and m).
Both the percentage of differentiated cells and the number of
branching points were significantly decreased in RNAi-PC12
cells (Figures 4l and m). Similar effects were observed with
the two RNAi sequences. We checked that these cell lines
did not show affected viability (Supplementary Figure 3).
To exclude off-target effects of the shRNA sequences, we
performed rescue experiments with a shRNA-resistant con-
struct of Ack1. This construct was generated by mutating the
nucleotide sequence that targets the shRNA of Ack1 but
maintaining the amino-acid sequence of the protein. We used
PC12 cell lines expressing RNAi-mediated Ack1 knock-down
and transfected them with the shRNA-resistant Ack1. This
construct effectively counteracted the effect of RNAi and
showed a more differentiated phenotype than in the PC12-
RNAi cells (Supplementary Figure 4).
Ack1 signaling modulates the PI3K and MAPK pathways
in response to neurotrophin stimulation. We analyzed
NGF-activated pathways in the PC12 cell lines in time-course
experiments, in which the cells were treated with 50ng/ml of
NGF for 5, 15, or 30min. Western blotting was used
to assess the extent of Akt and extracellular regulated kinase
1/2 (ERK 1/2) phosphorylation. In Ack1-overexpressing cells,
Akt phosphorylation in response to neurotrophins was
significantly higher and persisted for longer than in control
cells (Figures 5a and c). Conversely, analyses of PC12-RNAi
cells showed that the peak of Akt1 phosphorylation occurred
after 5–15min, but these increases were smaller than those
observed in control cells (Figures 5b and c) (P lower than
0.001 at 15min).
Similarly, phospho-Erk 1/2 levels were higher in PC12-Ack1
cells after 5min of NGF treatment and at 15–30min increased
phosphorylation levels were still detected (Figures 5a and d).
Moreover, Ack1 knock-downs resulted in a marked decrease
in the ERK 1/2 phosphorylation levels at 5–15min (Figures 5b
and d). In addition, pharmacological blockade of the PI3K or
MAPK pathways did not affect the neurotrophin-induced
phosphorylation of Ack1, whereas it did block phospho-Akt1
and phospho-Erk 1/2 levels. In a similar manner, this
pharmacological blockade does not affect the neurotrophin-
induced increase in kinase activity of Ack1 (Supplementary
Figure 5). Taken together, these data suggest that Ack1
Figure 2 Ack1 and Trk receptors interact both in transfected HEK 293T cells
and in brain lysates. HEK 293T cells were transiently transfected with Ack1-HA and
TrkA (a), TrkB-GFP (b), TrkC-myc (c), or p75 constructs (d). After immunoprecipita-
tion, we detected the corresponding partner when Ack1 and Trk receptors were
co-expressed (a–c, lane 4), but p75 and Ack1 failed to show any association (d, lane
4). Brain lysates from mouse embryos (E16) were subjected to immunoprecipitation
with anti-Ack1, anti-TrkB (Upstate), or anti-GFP as control. Endogenous Ack1 and
Trk receptors interacted in the developing brain (e and f, lane 2)
Ack1 in neurotrophin signaling
A La Torre et al
4
Cell Death and Disease
Figure 3 Neurotrophin treatment causes a re-organization of Ack1 in PC12 cells. Immunostaining analyses of PC12 cells showing the distribution of Ack1 in untreated
cells (a) and after NGF treatments (b). NGF stimuli promoted a redistribution of Ack1 protein, which is reflected in the presence of Ack1 in the cell edge (arrows). This
re-organization of Ack1 was detectable in460% of the cells (c). (d–i) Co-localization between Ack1 and NGF in PC12 cells after short stimulations with NGF. PC12 cells were
incubated with anti-Ack1 and anti-NGF. As previously described, a significant pool of Ack1 protein was detected in the cell membrane and these Ack1 aggregates greatly
co-localized with NGF. (j–l) Co-localization between Ack1 and TrkA in PC12 cells after a 5-min stimulation with NGF. As previously shown, a significant amount of Ack1 protein
was co-localized with TrkA in cell membrane clusters. Also, Ack1 significantly co-localized with F-actin in these discrete membrane edge regions (m–u). Scale bars: 25mm
(a and b), 20mm (d–f and m–r), and 10mm (g–l and s–u)
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activation is upstream of the PI3K and MAPK pathways and
that Ack1 protein levels regulate Akt1 and ERK 1/2 responses
to neurotrophins.
To ascertain whether the activation of Akt and ERK 1/2 can
be due, at least in part through Ras activation, we performed
Ras assay with different construct of Ack1: full-length (Ack1),
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Figure 5 Ack1 modulates Akt1 and MAPK pathways. (a) Starved PC12 cells lines (wild-type PC12 cells, lanes 1–4, PC12 cells stably transfected with an empty vector,
lanes 5–8; PC12 cells overexpressing Ack1i, lanes 9–12) were treated for 5, 15, 30, and 60 min with NGF (50 ng/ml) or left untreated (t¼ 0) (lanes 1, 5, and 9). Overexpression
of Ack1 enhanced the NGF-induced phosphorylation of Akt (panel 1, lanes 9–12) and ERK 1/2 (panel 3, lanes 9–12). Loading controls are in panels 2 and 4. (b) Starved PC12
cells lines (PC12 wild type, lanes 1–4; PC12 expressing two shRNAs against Ack1, lanes 5–12) were treated for 5, 15, 30, and 60 min with NGF (50 ng/ml) or left untreated
(t¼ 0) (lanes 1, 5, and 9). Ack1 knock-down counteracted the NGF-induced phosphorylation of Akt (panel 1, lanes 5–8 and 9–12) and ERK 1/2 (panel 3, lanes 5–8 and 9–12).
Loading controls are in panels 2 and 4. Quantification of NGF-induced phospho-Akt levels (c) and phospho-ERK (d) is illustrated. The mean data±S.E.M. of 3–6 separate
experiments are shown. Data were normalized to control t¼ 0. Groups compared with the T-test are indicated (*Po0.01; ***Po0.001)
Figure 4 Ack1 promotes differentiation in PC12 cells and this effect is enhanced by neurotrophins. (a) Phase-contrast morphology of PC12, PC12-pRK5 (empty vector),
and PC12-Ack1 cells at 3 days of culture in NGF-free medium. Scale bar: 50 mm. (b) Western blot analysis of Ack1 (top) and tubulin (bottom) in non-transfected PC12 cells
(wild type), PC12 cells transfected with an empty vector (PC12-pRK5), and Ack1-overexpressing cells (Ack1#1 and Ack1#2) (lanes 3 and 4). (c) Densitometric analysis of
western blot shows an increase in the immunoreactivity of PC12-Ack1 cells to Ack1 antibody. (d) Effects of Ack1 overexpression on cellular differentiation. PC12 lines were
plated and grown for the times indicated, and neurite outgrowth was analyzed. The number of differentiated cells is markedly increased upon Ack1 overexpression. Data are
represented as mean±S.E.M. Each group is compared with its corresponding control at day 1 of treatment (***Po0.001). (e–h) Ack1 overexpression exerts a differentiation
effect upon NGF treatments. PC12 lines were plated and grown in medium containing 50 ng/ml of NGF for the times indicated. The number of differentiated cells (f) and the
total neuritic length (g) was strikingly increased upon Ack1 overexpression. Phase-contrast morphology of PC12, PC12-pRK5 (empty vector), and PC12-Ack1 cells at several
days of culture is shown in (e). Scale bar: 50mm. At day 10 in NGF medium, control-PC12 and PC12-Ack1 cells had distinct morphologies, as illustrated in phase-contrast
micrographs (e). Ack1 overexpression induced a prominent increase in the number of branching points (h) and the neurites were significantly shorter. Data are represented as
mean±S.E.M. (**Po0.05; ***Po0.001). Each group was compared with its corresponding control at day 1. In (f–h), PC12-Ack1 and PC12-pRK5 (empty vector) are
compared with PC12 wild-type cells. (j) Western blot analysis showing that Ack1 RNAi (shRNA) reduces the expression of endogenous Ack1. The expression of Ack1 was
normalized by the analysis of actin expression (bottom panel). (k) Densitometric analysis of western blots reveal a reduction of 74% in one case and 67% in a second case in
the immunoreactivity to Ack1 antibody in the PC12-shRNA cells compared with scrambled-RNAi ones. (i, l, and m) Depletion of endogenous Ack1 partially counteracted NGF-
induced differentiation. (i) Phase-contrast micrographs of PC12 cells stably transfected with scrambled RNAi, or two shRNAs against Ack1 illustrate the morphology of these
lines after culture in NGF for 5 days in comparison with wild-type PC12 cells. Knock-down of endogenous Ack1 inhibited the neuritic differentiation phenotype and neuritic
arborization (l) promoted by NGF treatment for different periods. (m) Quantification of the number of branching points of PC12, PC12-scrambled RNAi, and PC12-RNAi lines
submitted to NGF treatment for 10 days. PC12-RNAi1 and PC12-RNAi-2 cells were compared with PC12-scrambled using the T-test (*Po0.01; **Po0.05). (**Po0.05;
***Po0.001). Scale bar: 50mm
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kinase hypoactive (Ack1-KD), and proline rich (Ack1-PR). We
performed this assay in PC12 cells and we observed
(Supplementary Figure 6) an increase in Ras active form
(Ras-GTP) after NGF stimulation, which was remarkably
lower when the construct was lacking the Ack1 kinase
(Ack1-PR) domain or wasmutated in the active site (Ack1-KD).
Ack1 regulates dendritic and axonal branching in
neurons in both BDNF-dependent and -independent
manners. We studied the effects of Ack1 overexpression in
neuronal branching. For this purpose, we used pyramidal
hippocampal neurons, a neuronal population whose neuritic
growth and branching is dependent on neurotrophin
actions.31–33 Thus, using primary hippocampal cultures, we
examined whether the Ack1-regulated neuronal differentiation
observed in PC12 cells is a general mechanism for
neurotrophin-induced arborization. At day 4 in vitro, primary
hippocampal neurons were transiently co-transfected with the
pEGFP-N3 vector together with an empty vector, Ack1-FL
cDNA, a kinase-dead construct (Ack1-KD), or an Ack1-
proline-rich region construct (Ack1-PR) lacking the kinase
domain (as a dominant negative). After 24h, the transfected
neurons were starved in control medium or treated with BDNF
(dosages: 5 and 20ng/ml). The neurons were fixed 48h later.
Hippocampal neurons were stained with anti-GFP and also
identified by neuronal morphology. First, we demonstrated
that the Ack1-KD and -PR constructs have decreased kinase
activity compared with Ack1-FL (Figure 1k), and that
transfection of these constructs in PC12 cells prevented
P-ERK activation by neurotrophins (Figures 6a–r).
Transfections with Ack1-FL construct dramatically
increased the number of branching points and therefore the
complexity of neuritic arbors in dendrites and axons of
hippocampal neurons, compared with GFP-transfected cells
(Figures 7a, b, g, h, e, and k). Furthermore, this phenomenon
was greatly enhanced by BDNF stimuli, similarly to Ack1-
overexpression effect previously described in PC12 cells
(Figures 7e and k). Interestingly, transfection with Ack1-PR, a
construct that lacks the entire kinase domain, blocked
increases in neurite branching (in the presence and in
the absence of BDNF), whereas transfection with the
Ack1-K158A construct resulted in intermediate effects
(Figures 7c–e and i–k).
We next measured total dendritic and axonal lengths
(Figures 7f and l). The effects of the Ack1 constructs on
axonal length were identical to those described above for
neurite branching, both in untreated neurons and in cells
incubated with BDNF (Figure 7f). In contrast, total dendritic
length of hippocampal neurons was significantly increased by
the Ack1 cDNA in control cultures and in neurons treated with
high BDNF concentrations (20 ng/ml), but not in those
incubated with moderate BDNF concentrations (5 ng/ml)
(Figure 7l).
To corroborate these findings, we next used P5 cerebellar
granule neurons to study the influence of endogenous Ack1
on the BDNF-induced differentiation in neurons. In this
neuronal type, transfection of several Ack1 constructs
(Ack1, Ack1-K158A, and Ack1-PR cDNAs) gave results
similar to those described above for hippocampal neurons
(Figures 8a–h and m–p).
To further confirm these observations, we performed
knock-down experiments in EGL neurons using shRNA
constructs (Figures 8i–l and q–r). First, we corroborated
that the shRNA sequences designed effectively decreased
endogenous Ack1 protein levels in neurons (Figures 6s–z).
Knock-down of endogenous Ack1 did not affect branching
parameters in unstimulated control neurons; however, it did
result in a decrease in both dendritic and axonal branching
upon BDNF incubations. This decrease was statistically
significant at high BDNF concentrations (20 ng) (Figures 8i–
l, q, and r). Taken together with the results obtained in PC12
cells, we conclude that endogenous Ack1 protein levels
modulate neurotrophin-induced branching.
Discussion
Ack1 is expressed mainly in the CNS and high levels of Ack1
protein are detected in developing dendrites and axons.24,25
Although some relevant protein–protein interactions have
been reported, the signaling network in which Ack1 operates
has been described only in part. Ack1 has been shown to
interact with many signaling molecules, including receptor
tyrosine kinases and molecular adaptors such as Grb2 and
Nck.13,21 Ack1 also associates with actin cytoskeleton
regulators like Cdc4212,34 and WASP.19 Interestingly, Ack1
also binds to Ras-GRF1, a Trk-interacting molecule related to
neuronal differentiation.17,35,36 Furthermore, Ack2 overex-
pression promotes cellular differentiation in NIH3T3 cells15
and Ack2 molecules direct the formation of membrane
protrusions in transformed cells lines.37 In addition, the
Drosophila homolog of Ack1 regulates axonal guidance by
the phosphorylation of a WASP-binding partner, the sorting
nexin DSH3PX1.38 All these findings suggest that Ack1 is
involved in the regulation of several cytoskeletal and
transduction pathways that ultimately lead to neuronal
differentiation. Therefore, the purpose of the present study
was to analyze the pathways regulated by Ack1 and elucidate
the contribution of this kinase to the neuronal differentiation
and polarization processes.
Here, we provide evidence suggesting that Ack1 has a
relevant role in neurotrophin signaling pathways during
neuronal polarization. We demonstrate that Ack1 is tyrosine
phosphorylated in response to all the neurotrophic factors
studied, thereby supporting the notion of a general role for this
kinase in neurotrophin transduction pathways. Moreover, our
results show that the neurotrophin receptors Trk and Ack1
interact whereas p75NTR does not bind to Ack1. These
observations lead us to propose that Ack1 is involved in Trk
signaling events. We also show the influence of Ack1 on
functional processes triggered by neurotrophins such as
differentiation in PC12 cells.
In addition, Ack1 overexpression induced neuritic arboriza-
tion in all the models tested. In the same regard, the
expression of dominant-negative constructs or knock-down
experiments resulted in a decrease in neurite differentiation
and elaboration.
We found that the proline-rich C-terminus region is
essential for coupling to Trk receptor signaling molecules
and for mediating the biological activities of Ack1. Therefore,
overexpression of the sole proline-rich region acts as a
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dominant negative. Consistent with our data, previous studies
report that the biological functions of Ack1 molecules require
interactions mediated through the proline-rich domain.16,21,39
In conclusion, our results have identified a novel function of
Ack1 protein in the mediation of neurite outgrowth and
branching in neuronal cells, and indicate that Ack1 protein is
a novel component of the Trk signaling cascade.
ERK 1/2 and Akt1 phosphorylation has a pivotal role in
promoting neurite outgrowth in response to neurotrophins.40
Our biochemical data demonstrate that Ack1 signaling
Figure 6 NGF triggers P-ERK immunolabeling in cells overexpressing Ack1 and shRNA sequences downregulate endogenous Ack1 levels in neurons. (a–r) Ack1 kinase-
dead and Ack1 proline-rich constructs counteracted ERK activation induced by NGF at 00, 50, and 150. PC12 cells were transfected with either pRK5-Ack1 or pRK5-Ack1 KD or
pRK5-Ack1-PR and pAcEGFP vectors and labeled with anti-GFP and anti-P-ERK antibodies. Large arrows show cells overexpressing Ack1 and short arrows untransfected
cells. Green fluorescence shows cells positive for Ack1 and red fluorescence cells positive for P-ERK. While cells expressing Ack1 presented activated ERK (g, h, m, and n),
those expressing either Ack1-KD (i, j, o, and p) or Ack1 PR (k, l, q, and r) showed lower activation of ERK. Scale bars: 25 mm (s–z). Neurons transfected with shRNA for Ack1
presented lower Ack1 expression. Hippocampal neurons were transfected with pAc-EGFP (s and t) and two shRNAs for Ack1 (u, v, w, and x) or a scrambled sequence of
shRNA (y and z). Cells were stained with anti-Ack1 antibodies (s, u, w, and y) or anti-GFP (t, v, x, and z). Arrows show cells expressing Ack1 and GFP. Scale bars: 10 mm
Ack1 in neurotrophin signaling
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regulates the MAPK and Akt pathways; in line with this
premise, overexpression of Ack1 promoted a higher activation
of ERK 1/2 and Akt1 whereas endogenous Ack1 knock-down
partially counteracted NGF-induced activation.
The process of neurite formation requires the assembly of
cytoskeletal elements at specific membrane sites. Upon
neurotrophin stimuli, Ack1 is recruited to precise localizations
in the membrane edge, and it is possible that the Ack1
signaling pathway locally modifies the dynamics of actin
fibers. The morphological changes that neurons undergo
during their development require the re-organization of the
actin cytoskeleton along with an increase in peripheral actin
filaments.41 It has been well documented that the loss of
stress fibers results in cell membrane protrusions and
neuronal differentiation.42,43 Other molecules regulating actin
dynamics such as Rho kinase have been demonstrated to
Figure 7 Ack1 enhances BDNF-dependent neuritic outgrowth and branching in hippocampal neurons. Primary hippocampal neurons were transfected with pEGFP
(a and g) or co-transfected with pEGFP and Ack1 (b and h), Ack1 (K158A) (c and i) or the proline-rich construct (d and j), at day 4 in vitro and fixed 3 days later. Neurons were
treated with a range of dosages of BDNF (control experiment, 5 or 20 ng/ml of BDNF). (a–d) Untreated cells and (g–j) transfected neurons treated with 5 ng/ml of BDNF for 2
days are shown. The number of branching points of axons and dendrites of GFP-immunopositive neurons was markedly increased upon Ack1 overexpression, as also shown
by quantitative analyses (e and k). The length of axons (f) and dendrites (l) was also measured in GFP-immunopositive neurons. The data are represented as mean±S.E.M.
of five separate experiments. Data were normalized to control values (pEGFP transfection). Each treatment group at 5 and 20 ng/ml was compared with its corresponding
control using the T-test (*Po0.01; **Po0.05; ***Po0.001). Scale bars: (a–d) 25mm; (g–j) 15mm
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Figure 8 Ack1 promotes BDNF-induced arborization in EGL neurons. (a–h) Cerebellar granule neurons were transfected with pEGFP (a and b) or co-transfected with
pEGFP and Ack1 (c and d), Ack1 (K158A) (e and f) or the proline-rich construct (g and h), at day 1 in vitro and fixed 48 h later. Neurons were treated with a range of dosages of
BDNF (a, c, e, and g, control experiment; b, d, f, and h, 5 ng/ml of BDNF). The number of branching of GFP-immunopositive neurons was markedly increased upon Ack1
overexpression, as also shown by quantitative analyses (m and o). (n and p) Quantification of axonal and dendritic length. (i–l) Cerebellar granule neurons were transfected
with EGFP and either scrambled (i and j) or shRNA for Ack1 (k and l), in the absence (i and k) or presence of 5 ng/ml BDNF (j and l). (q and r) Quantification of dendritic and
axonal branching. The mean data±S.E.M. of five separate experiments are shown. Data were normalized to control values (pEGFP transfection). Each treatment group
at 5 and 20 ng/ml was compared with its corresponding control using T-test (*Po0.01; **Po0.05; ***Po0.001). Scale bars: 20mm
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have a role in dendritic dynamics;44 a functional connection
between Ack1 and Rho kinase cannot be excluded although
no data are available at present from the literature.
Our data also provide evidence that Ack1 promotes neurite
branching and extension in PC12 cells and hippocampal and
granule cell neurons even without the addition of NGF/BDNF.
We thus propose that Ack1 has two independent, though
interconnected, roles: by itself it would promote axonal and
dendritic outgrowth, even independently of neurotrophins,
and would also be downstream of Trk receptor activation. The
receptor/signaling pathways and cascades that activate Ack1
protein in neurons to mediate neurite branching and extension
in a neurotrophin-independent way remain to be determined.
In summary, the present study indicates that the tyrosine
kinase Ack1 is a novel component of the neurotrophin
signaling pathway as well as a protein that regulates neural
extension and branching. In mature neurons, neurotrophin
signaling is also required for synaptic plasticity-related events,
and actin is a major cytoskeletal component required for
dendritic spine morphological plasticity.7,45–49 Ack1 localizes
to both the pre- and the post-synaptic compartments. Thus,
our data linking Ack1 to neurotrophin signaling together with
the observation that its expression is regulated by neuronal
activity25 suggest that Ack1 may exert a further potential role
in synaptogenesis and synaptic plasticity events that would be
addressed in future work.
Materials and Methods
Animals. OF1 embryos and postnatal mice (Charles River, Lyon, France) were
used in this study. The mating day was considered as embryonic day 0 (E0) and
the day of birth postnatal day 0 (P0). All experimental procedures with mice were
performed in accordance with the guidelines approved by the Spanish Ministry of
Science and Technology and following the European Community Council Directive
86/609 EEC.
Reagents. NGF was purchased from Peprotech Inc., (Neully sur Seine,
France) and BDNF and NT-3 were obtained from Promega (Madison, WI, USA).
Polyclonal antibody against Ack1 (384) was generated using the GST fusion
proteins corresponding to the proline-rich region (amino acids 502–1008), as
described elsewhere.25 Monoclonal antibodies against Ack1 were generated by the
company Leitat (Barcelona, Spain). As antigen, the same GST fusion protein
encoding amino acids 502–1008 of Ack1 used for polyclonal antibodies was utilized.
After injections of mice with the purified protein, standard procedures were followed
to obtain the antibodies.50
Antibodies against phosphotyrosine (clone 4G10), TrkA, TrkB and TrkC were
from Millipore (Billerica, MA, USA). A second anti-Trk A antibody was from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Anti-pan-Trk (a-203) has been
described previously.51 Anti-phospho-p42/p44 MAP kinase (Thr202/Tyr204) and
anti-phospho-Akt (Ser 473) antibodies were from Cell Signaling Technology
(Danvers, MA, USA). Anti pan-ERK was obtained from BD Transduction
Laboratories (San Diego, CA, USA). The antibody against Akt1 (C-20) was
purchased from Santa Cruz Biotechnology. Anti-GFP was from Molecular Probes/
Invitrogen (Carlsbad, CA, USA) and from Sigma (St. Louis, MO, USA), anti-actin
from Chemicon (Temecula, CA, USA), and anti-HA (clone 3F10), anti-tubulin (clone
KMX-1), and anti-myc (clone 9E10) from Roche (Basel, Switzerland).
Phalloidin-FITC and Hoechst (Bisbenzimide) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Alexa Fluor 488 goat anti-mouse immunoglobulin G (IgG)
(Hþ L) and Alexa Fluor 568 goat anti-rabbit immunoglobulin G (IgG) (Hþ L) were
from Molecular Probes/Invitrogen. The goat anti-mouse-HRP, the swine anti-rabbit-
HRP, and rabbit anti-goat-HRP secondary antibodies used in the western blot were
purchased from Dako (Glostrup, Denmark). Goat anti-rabbit-HRP was from Sigma.
Protein G-Sepharose 4B Fast Flow was purchased from Sigma and Glutathione-
Sepharose 4B beads from Amersham (Little Chalfont, UK). The inhibitors PD
98059,LY 294002, PP2, and PP3 used in the experiments were supplied by
Calbiochem (San Diego, CA, USA).
cDNA constructs. The full-length Ack1 (Ack1-FL) tagged at the amino-
terminus with HA, and the proline-rich-GST constructs were generated as
described previously.25 The Ack1 kinase-defective mutant (K158A) was generated
by PCR-directed mutagenesis. Primer sequences: forward (50–30) GTGAGTGT
GGCCGTGGCATGCCTGAAACCT, reverse (50–30) AGGTTTCAGGCATGCCACG
GCCACACTCAC, the underlined codons correspond to the mutation introduced.
The mutated sequence was confirmed by DNA sequencing. To knock-down
endogenous Ack1, we used Sigma Mission Lentiviral Packaging shRNA
technology, following the manufacturer’s instructions (Sigma). Five shRNA
lentiviral constructs either against Ack1 (clone ID NM_005781.4) or control RNA
(scrambled) were used to generate stable PC12 cell lines. After puromycin
selection, we tested the efficiency of each construct by western blot. GFP lentiviral
plasmid was used as a positive transfection control.
Cell culture and transfection. HEK 293T cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) with 10% heat-inactivated fetal bovine serum
(FBS), 20 U/ml penicillin, and 20mg/ml streptomycin. PC12 cells were grown on
the same DMEM supplemented with 10% heat-inactivated FBS and 5% heat-
inactivated horse serum (HS), 20 U/ml penicillin and 20 mg/ml streptomycin. All
cells were maintained in 5% CO2 at 371C. For transfection, the cells were cultured
overnight to 40–60% confluence. Transfection was performed with the
Lipofectamine Plus transfection reagent, following the manufacturer’s instructions
(Invitrogen). For immunoprecipitation and pull-down assays, 4 mg of DNA was
used in 90-mm culture plates. PC12 cells were transfected with the desired
plasmid using Lipofectamine 2000 reagent (Invitrogen), following the manufac-
turer’s instructions.
Western blot and immunoprecipitation assays. Embryonic, post-
natal and adult brains, as well as primary cultures, PC12 cells and transiently
transfected HEK 293T cells were collected in lysis buffer: 50 mM HEPES
(4-2 hydroxyethyl-1-piperazine ethansultanic acid), pH 7.5, 150 mM sodium
chloride, 1.5 mM magnesium chloride, 1 mM EGTA (ethylene glycol-bis
(2-aminoethylether)-N,N,N0,N0-tetraacetic acid), 10% glycerol, and 1% Triton
X-100, containing a protease inhibitor cocktail (Roche) and phosphatase inhibitors
(10 mM tetra-sodium pyrophosphate, 200mM sodium orthovanadate and 10 mM
sodium fluoride). Cells were then centrifuged at 13 000 r.p.m. for 20 min and the
pellet was discarded. The supernatant was analyzed either by western blot or
subjected to immunoprecipitation. For tissue extracts, samples were weighed and
five volumes of lysis buffer were added. The mixture was processed using a
Polytron homogenizer and insoluble material was removed by centrifugation at
13 000 r.p.m. for 20 min. For immunoprecipitation experiments, antibodies were
added to 500mg of total protein of cell lysates or tissue extracts, which were then
incubated for 3 h at 41C. As a control, a rabbit or mouse antibody (IgG)
respectively was used under the same conditions. Sepharose coupled to protein G
(Sigma) was then added and the suspension was incubated for 2 h at 41C. After
this period, Sepharose beads were washed with lysis buffer five times, then
suspended in 50ml of Lysis buffer and 25ml of Laemmli loading buffer (25 mM Tris
pH 6.5, 0.17 mM b-mercaptoethanol, 2% SDS, 10% glycerol, and 0.0025%
bromophenol blue) were added and the samples were analyzed by SDS-PAGE.52
Samples were run in an 8% polyacrylamide gel at 120 V, after which they were
transferred onto a nitrocellulose membrane in 120 mM glycine, 125 mM Tris, pH 8.5
and 20% methanol. Filters were then saturated in 3% BSA in TBS and incubated
with the antibodies. Detection was performed using the ECL system from
Amersham. For quantification, films were scanned and then subjected to band
densitometry and quantification (Bio-Rad, Hercules, CA, USA).
Kinase assay. To determine Ack1 activity, we used the Tyrosine Kinase
Assay Kit (Cat no. 17-315) from Upstate Cell Signaling Solutions/Millipore
(Billerica, MA, USA) following the manufacturer’s instructions. In brief, we used
transfected HEK 293T cells, PC12 cells, or hippocampal neurons, plated onto
35-mm cell culture dishes (Nunc, Roskilde, Denmark) and stimulated with NGF,
BDNF, or NT-3 for a range of times (0, 5, 15, 30, and 60 min) and in some cases
treated with PI3K inhibitor (LY294002, 50 mM) or with MERK inhibitor (PD 98059,
50mM); the cells were lysed and immunoprecipitated with anti-Ack1 antibodies as
described above. The immunoprecipitated Ack1 was assayed in a 30-min reaction
in 1 mM sodium orthovanadate, 5 mg/ml 1 mM, Poly (Glu4-Tyr) peptide, conjugated
biotin, 20 mM Tris-HCl pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 1 mM dithiothreitol and
200mM ATP. The reaction was stopped by heat inactivation (5 min at 951C)
and transferred to ELISA plates. Phosphotyrosine was detected with conjugated
Ack1 in neurotrophin signaling
A La Torre et al
12
Cell Death and Disease
anti-phosphotyrosine antibody-HRP and tetramethylbenzidine reagent coupled to
hydrogen peroxide in citrate buffer, following the manufacturer’s instructions.
Quantification was done by spectrophotometric absorbance measurements at
450 nm.
PC12 differentiation. PC12 cells were grown and maintained as described
above. Differentiation was stimulated with 50 ng/ml of NGF in DMEM containing
0.5% NHS and allowed to proceed for up to 10 days.
Generation of shRNA-resistant Ack1 and rescue experiments.
An Ack1 resistant to shRNA was generated by site-directed mutagenesis with
QuickChange XL Site-Directed Mutagenesis Kit (Stratagene, Agilent Technolo-
gies, Santa Clara, CA, USA), following the manufacturer’s instructions. The
following primers were used to amplify Ack1: Forward (50–30): CATGTGCAAACG
CAAAAGTTGGATGTCCAAGGTGTTCAGTG and Reverse (50–30): CACTGAAC
ACCTTGGACATCCAACTTTTGCGTTTGCACATG.
For rescue experiments, Ack-RNAi-PC12 cells were grown and maintained as
above described. For our purposes, 20 000 cells were seeded in 35-mm plates and
grown overnight in complete medium. The next day, cells were transfected with
Lipofectamine 2000 (Invitrogen) and 0.8mg of DNA per plate and left 1 more day in
complete medium. The following day, cells were deprived overnight in DMEM
containing 0.5% normal HS, and then differentiation was stimulated with 50 ng/ml
NGF in the same medium and allowed to proceed for up to 10 days. During this time,
photographs of random fields were taken with an inverted microscope Nikon TE200
(Izasa, Barcelona, Spain) equipped with optics coupled to a digital camera. Neurite
outgrowth was quantified using ImageJ software (Wayne Rasband, NIH).
Cell viability. Several lines of PC12 cells stably expressing Ack1, RNAi-1, RNAi-
2, or Scr were used. To determine cell viability, we used the WST-1 cell viability assay
from Roche (Mannheim, Germany), following the manufacturer’s instructions.
Paraformaldehyde fixation, immunofluorescent staining, and
F-actin staining. Cells were fixed with 4% paraformaldehyde in PBS (pH 7.4)
for 30 min or frozen methanol for 15 min. For immunocytochemistry, cells were
permeabilized and blocked with 0.1% Triton X-100 (Sigma) and 10% normal goat
serum in PBS for 1 h, washed with PBS and incubated with primary antibodies or
Phalloidin-FITC diluted in PBS (polyclonal Ack1 1 : 100; monoclonal Ack1 1 :25,;
anti-GFP 1 : 1000; monoclonal NGF 1 : 100; Trk A 1/100, pan-Trk 203 antibody
1 : 1000; p-ERK 1 : 1000, Phalloidin-FITC 1 : 500) for 2 h. After being washed with
PBS, cells were incubated with either secondary antibodies goat anti-mouse-488
and goat anti-rabbit-568 or goat anti-rabbit-488 (Alexa Fluor, Invitrogen) for 1 h.
Coverslips were washed with PBS and mounted on glass slides. All procedures
were carried out at room temperature.
Neuronal primary cultures and transfection. For hippocampal
primary cultures, E16 mouse brains were dissected and dissociated, as described
before.25 Primary hippocampal neurons were seeded (3 106 cells per 35-mm
dish for biochemical analyses and 100 000 cells per coverslip in transfection
experiments) on dishes or coverslips pre-coated with poly-D-lysine (Sigma).
Cerebellar granule cell cultures were performed as described by Hatten and
collaborators.53 After granule cell purification, we plated 150 000 neurons plated
on poly-L-lysine (Sigma) pre-coated coverslips. Neuron transfections were
performed at day 4 (hippocampal neurons) and day 1 (granule cells), following
the instructions of the manufacturer, using 1 ml of Lipofectamine 2000 (Invitrogen)
and 1 mg of DNA per well of a 24-well plate. Co-transfections of Ack1 constructs
and pEGFP plasmids were performed at a proportion of 5 : 1 (Ack1:EGFP). For
RNAi induction, we co-transfected neurons with EGFP- and shRNA-containing
plasmids from the MISSION shRNA library corresponding to Ack1 (NM_005781.4)
in the above-mentioned proportion 5 : 1 (shRNA:EGFP).
Quantification of neurite outgrowth and branching. In PC12
differentiation experiments, photographs of random fields were taken 1–10 days
after NGF treatments using an inverted microscope Nikon TE200 equipped with
optics coupled to a digital camera. Neurite outgrowth was measured using the
AnalySIS software (Soft Imaging System, Munster, Germany) and ImageJ
software. In each experiment, a minimum of 150 cells were measured per
condition. Cells were considered as differentiated when they presented one
neurite 1.5 times longer than the soma.
Labeled EGL or hippocampal neurons were visualized and digitally acquired in a
Nikon TE1000 microscope (Nikon Instruments, Izasa). For each condition studied,
we selected about 50–60 cells. Neuritic arbors were traced and analyzed with
AnalySIS software or by direct counting of the branching points and other
topological parameters. Co-localization experiments were performed using a Leica
TCS SP2 AOBS confocal microscope. For statistical analyses, we used Excel 2003.
Determination of Ras activity. To determine Ras activity, we used a Ras-
activation assay kit from Millipore. In brief, the assay consists of pulling down
active Ras (Ras-GTP) with GST–Raf1 RBD coupled to glutathione-agarose,
followed by Ras detection using a pan-Ras antibody.
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